Kairos Pharma, LTD. (KAPA)
About Kairos Pharma, LTD.
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$5.4M
- Total assets
- $6.5M
- Market cap
- $9.4M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $5.6M
- Operating income
- -$5.6M
- Net income
- -$5.4M
- EPS (basic)
- $-0.30
- EPS (diluted)
- $-0.30
Balance sheet
- Total assets
- $6.5M
- Current assets
- $5.4M
- Total liabilities
- $199.0K
- Current liabilities
- $199.0K
- Shareholders’ equity
- $6.3M
Cash flow
- Operating cash flow
- -$3.4M
- Investing cash flow
- -$3.2M
- Financing cash flow
- $6.7M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $9.4M
- EPS (diluted)
- $-0.3
- Shares outstanding
- 33.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 16, 2024
Kairos Pharma, LTD. (KAPA) Stock Price
- Reported a net loss of $5.4M.
- Trading 86% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Kairos Pharma, LTD..
Write a review
News about Kairos Pharma, LTD.
News & sentiment via Polygon.io
Kairos Pharma, LTD.: frequently asked questions
Is Kairos Pharma, LTD. an American company?
Kairos Pharma, LTD. is a US-based company headquartered in Los Angeles, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Kairos Pharma, LTD. headquartered?
Kairos Pharma, LTD. is headquartered in Los Angeles, California, United States.
Is Kairos Pharma, LTD. publicly traded?
Yes — Kairos Pharma, LTD. is a publicly traded company. Its stock trades under the ticker symbol KAPA on the NYSE.
What does Kairos Pharma, LTD. do?
Kairos Pharma, LTD. is an American Pharmaceuticals company in the Health & Beauty sector.
